z-logo
open-access-imgOpen Access
Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon
Author(s) -
Henrik Falconer,
J.M. Mwenda,
Daniel Chai,
Carrie Wagner,
X.-Y. R. Song,
Attila Mihalyi,
Péter Simsa,
Cleophas Kyama,
Freddy Cornillie,
Agneta Bergqvist,
Gerald M. Fried,
Thomas D’Hooghe
Publication year - 2006
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/del044
Subject(s) - baboon , endometriosis , placebo , medicine , laparoscopy , lesion , menstrual cycle , monoclonal antibody , gastroenterology , urology , surgery , pathology , antibody , immunology , hormone , alternative medicine
Inflammatory cytokines, including interleukin (IL)-1, IL-6, IL-8 and tumour necrosis factor-alpha (TNF-alpha), are important in the pathogenesis of endometriosis. We assessed the efficacy of anti-TNF monoclonal antibody (mAb, c5N), known to prevent induced endometriosis in baboons, in reducing established endometriosis in baboons.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom